Genomic technologies like whole-genome sequencing enable the detailed characterization of pathogens at the genetic level. This information can reveal mutations responsible for virulence or antibiotic resistance, aiding in the development of targeted treatments and vaccines. During the COVID-19 pandemic, genomic surveillance was key to identifying new variants and understanding their impact on transmission and vaccine efficacy.
